肝病中西医结合治疗中临床路径的应用  

Clinical pathway application of integrated traditional Chinese medicine and western medicine in liver diseases

作　　者：罗晓岚[1] 李秀惠[1] 杨华升[1] 田一梅[1] 许文君[1] 邱金鹏[1] 于飞[1] 

机构地区：[1]首都医科大学附属北京佑安医院中西医结合科,100069

出　　处：《北京医学》2012年第6期456-458,共3页Beijing Medical Journal

摘　　要：目的研究临床路径在肝病中西医结合治疗的价值。方法将急性肝炎、肝硬化代偿期患者各30例、慢性肝炎患者20例分为临床路径组及对照组,比较两组治疗天数、费用及疗效。结果路径组平均治疗天数和治疗费用明显低于对照组[(23.6±3.2)dvs.(31.1±5.3)d,(3756.52±1093.1)元vs.(5063.54±1690.1)元,P均<0.05]。路径组与对照组临床治疗总有效率分别为95.0%和87.5%,路径组明显优于对照组(P<0.05)。结论在肝病的中西医结合治疗中,构建合理的临床路径,制定最佳的诊疗方案,可缩短治疗时间、降低治疗费用、提高临床疗效,值得在临床中广泛推广应用。Objective To study the value of clinical pathway application of integrated traditional Chinese medicine and western medicine in liver diseases.Methods Thirty cases of acute hepatitis and 30 cases of compensented cirrhosis,20 cases of chronic hepatitis were divided into pathway group and control group.Treatment days,medical expenditure and clinical efficacy were compared between the two groups.Results The average treatment days and the mean medical expenditures of pathway group were lower than those of the control group [（23.6±3.2）days vs.（31.1±5.3）days,（3756.52±1093.1）yuan vs.（5063.54±1690.1）yuan,P 〈0.05].The total effective rate of pathway group was higher than control group（95.0% vs.87.5%,P 〈0.05）.Conclusion Application of rational clinical pathway and treatment methods can reduce the treatment time and medical expenditure,raise medical efficacy as well.It is worth widely applying in clinical.

关 键 词：肝病 临床路径 中西医结合 

分 类 号：R575[医药卫生—消化系统]